DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OMNIPAQUE 70

« Back to Dashboard

All Clinical Trials for Omnipaque 70

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00478556 ↗	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	GE Healthcare	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT00478556 ↗	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	University of Alabama at Birmingham	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT00587132 ↗	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	ChiRhoClin, Inc.	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT00587132 ↗	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	Mayo Clinic	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.

Clinical Trial Conditions for Omnipaque 70

Condition Name

Condition Name for Omnipaque 70
Intervention	Trials
Healthy	1
Ischemic Heart Diseases	1
Batten Disease	1
Uterine Fibroids	1

Condition MeSH

Condition MeSH for Omnipaque 70
Intervention	Trials
Myocardial Ischemia	2
Coronary Artery Disease	2
Toxemia	1
Pancreatic Neoplasms	1

Clinical Trial Locations for Omnipaque 70

Trials by Country

Trials by Country for Omnipaque 70
Location	Trials
United States	10
France	1
Korea, Republic of	1
Colombia	1

Trials by US State

Trials by US State for Omnipaque 70
Location	Trials
Minnesota	2
North Carolina	1
Pennsylvania	1
Ohio	1
Florida	1

Clinical Trial Progress for Omnipaque 70

Clinical Trial Phase

Clinical Trial Phase for Omnipaque 70
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Omnipaque 70
Clinical Trial Phase	Trials
Completed	7
Recruiting	5
Not yet recruiting	4

Clinical Trial Sponsors for Omnipaque 70

Sponsor Name

Sponsor Name for Omnipaque 70
Sponsor	Trials
GE Healthcare	2
University of California, San Diego	1
National Institutes of Health (NIH)	1

Sponsor Type

Sponsor Type for Omnipaque 70
Sponsor	Trials
Other	16
Industry	11
NIH	3